That's my point - if the price goes low enough, anyone would buy them. But then we get screwed.
But honestly, I think the lost patent, and the extreme resistance in Europe is probably scaring potential buyers away. If V was flying off the shelves, we could name our price.
It all goes back to the fact that they should have sold post-Reduce-it, before anyone knew how badly commercialization would fail. Amarin just blew it. But it probably would have done incredibly well in the hands of a BP. Hell, we flew to $600M revenue in the U.S. in just a few years.
Market Data 
Markets 
AI
